Regencell Bioscience HoldingsRGC 
$5.00-6.19%24h
-6.19%24h
Global rank4128
Market cap$65.06M
Change 7d-11.97%
YTD Performance-52.38%
SP500 benchmarkUnderperform
P/E-11.11
P/S0
Revenue$0
Earnings-$6.06M
Dividend yield-
Main Sector
Healthcare
Category
Regencell Bioscience Holdings (RGC) Net Assets
RGC Net Assets in 2023: $11.99M
As of 17 Dec 2024, Regencell Bioscience Holdings net assets is $11.99M, an decrease of -29.81% to 2022. Net assets are calculated as total assets minus total liabilities. This value represents the Regencell Bioscience Holdings overall net worth, providing an insight into company's financial health and stability. Net assets are a key indicator of a stock value, reflecting what it essentially owns minus what it owes.
Regencell Bioscience Holdings Net Assets History from 2019 to 2024
-
Value:-
RGC Net Assets History by year
| Year | Net assets | Change |
|---|---|---|
| 2023 | $11.99M | -29.81% |
| 2022 | $17.08M | -527.27% |
| 2021 | $-4.00M | 50.80% |
| 2020 | $-2.65M | 44.17% |
| 2019 | $-1.84M | - |
View the Top Net Assets Companies
